Clinical trials
Urinary Bladder Neoplasms trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
| Completed | 8 |
| Recruiting | 5 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 5 |
| Merck Sharp & Dohme LLC | 4 |
| Janssen Research & Development, LLC | 3 |
| AstraZeneca | 2 |
| Pfizer | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| Acrotech Biopharma Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| BicycleTx Limited | 1 |
| Nektar Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 24 |
| Carcinoma, Transitional Cell | 5 |
| Non-Muscle Invasive Bladder Neoplasms | 4 |
| Carcinoma in Situ | 2 |
| Neoplasm Metastasis | 2 |
| Carcinoma | 1 |
| Neoplasms | 1 |
| Recurrence | 1 |
| Ureteral Neoplasms | 1 |
| Urologic Neoplasms | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.